Where Computer Intelligence
Meets Living Systems
AI Biotechnologies harnesses machine learning, large-scale genomics, and autonomous lab platforms to accelerate the discovery of medicines, understand disease, and make personalized care a reality for every patient.
Four Pillars of AI Biotech Research
From molecule design to patient-matched treatment, our programs span the full arc of biotech innovation — all powered by AI.
Machine learning identifies novel therapeutic targets and generates optimized drug candidates in a fraction of traditional timelines.
ExploreStructure prediction tools decode how proteins fold and function — unlocking new design strategies for enzymes, antibodies, and therapeutics.
ExploreAI reads massive genomic datasets to surface disease-linked variants, enabling diagnoses and treatments matched to individual patient biology.
ExploreAI-controlled robotics and smart bioreactors run experiments and scale bio-manufacturing with precision that human-only labs cannot match.
ExploreSpeed. Cost. Accuracy.
AI Biotechnologies delivers measurable advantages across every stage of biotech research and development.
AI cuts drug creation timelines from years down to months by running millions of molecular simulations simultaneously — where traditional labs test one candidate at a time.
Smart computer simulations replace expensive laboratory assays, dramatically lowering the cost of early-stage drug screening, protein testing, and genomic analysis.
Machine learning surfaces hidden patterns in genomic, proteomic, and clinical data that human researchers miss — leading to higher-confidence drug targets and fewer late-stage failures.
Merging Intelligence With Biology
Founded in 2017 by Philip Odegard as an initiative of the Odegard Foundation, AI Biotechnologies exists to collapse the gap between computational power and biological discovery. We fund and conduct research at the intersection of machine learning, bioinformatics, and wet-lab science.
Our work spans drug discovery, protein engineering, genomic medicine, and autonomous laboratory systems — all unified by a belief that AI is the most powerful tool ever developed for understanding life itself.
Learn About UsAI Biotechnologies was created to give researchers the computational tools biology has always needed but never had.
We fund research at the intersection of artificial intelligence, genomics, proteomics, and lab automation for the benefit of human health.
An initiative of the Odegard Foundation, committed to science that serves humanity.
From the Foundation
Our generative chemistry platform screened over 400 million molecular configurations to surface three previously unknown binding sites in treatment-resistant tumors.
Drug DiscoveryOur structure prediction pipeline reached benchmark accuracy surpassing X-ray crystallography speed by 1,000× on a curated set of industrially relevant enzymes.
Protein ScienceA collaboration with three clinical research centers demonstrated our ability to identify polygenic risk scores for rare diseases at population scale with high fidelity.
Genomics